FR2355823B1 - - Google Patents

Info

Publication number
FR2355823B1
FR2355823B1 FR7715320A FR7715320A FR2355823B1 FR 2355823 B1 FR2355823 B1 FR 2355823B1 FR 7715320 A FR7715320 A FR 7715320A FR 7715320 A FR7715320 A FR 7715320A FR 2355823 B1 FR2355823 B1 FR 2355823B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7715320A
Other languages
French (fr)
Other versions
FR2355823A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of FR2355823A1 publication Critical patent/FR2355823A1/fr
Priority to US05/905,845 priority Critical patent/US4229342A/en
Application granted granted Critical
Publication of FR2355823B1 publication Critical patent/FR2355823B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
FR7715320A 1976-05-21 1977-05-18 Derives isoindoliques Granted FR2355823A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US05/905,845 US4229342A (en) 1977-05-18 1978-05-15 Process for extracting proteins from milk using silica and anion exchange resins

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH645476 1976-05-21
CH287677 1977-03-08
US05/789,905 US4122265A (en) 1976-05-21 1977-04-22 Derivatives of 3-phenylisoindole-1-carboxylic acid
US05/928,135 US4167632A (en) 1976-05-21 1978-07-26 Derivatives of 3-phenylisoindole-1-carboxylic acid

Publications (2)

Publication Number Publication Date
FR2355823A1 FR2355823A1 (fr) 1978-01-20
FR2355823B1 true FR2355823B1 (Direct) 1981-01-09

Family

ID=27428523

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7715320A Granted FR2355823A1 (fr) 1976-05-21 1977-05-18 Derives isoindoliques

Country Status (9)

Country Link
US (2) US4122265A (Direct)
JP (1) JPS52142059A (Direct)
AU (1) AU510035B2 (Direct)
BE (1) BE854780A (Direct)
CA (1) CA1079288A (Direct)
DE (1) DE2723186A1 (Direct)
FR (1) FR2355823A1 (Direct)
GB (1) GB1568259A (Direct)
NL (1) NL7705590A (Direct)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW263504B (Direct) * 1991-10-03 1995-11-21 Pfizer
WO2017214442A1 (en) 2016-06-08 2017-12-14 President And Fellows Of Harvard College Methods and compositions for reducing tactile dysfunction and anxiety associated with autism spectrum disorder, rett syndrome, and fragile x syndrome
AU2019272778B2 (en) 2018-05-22 2024-10-03 President And Fellows Of Harvard College Compositions and methods for reducing tactile dysfunction, anxiety, and social impairment
CA3099791A1 (en) 2018-05-29 2019-12-05 President And Fellows Of Harvard College Compositions and methods for reducing tactile dysfunction, anxiety, and social impairment
US12077512B2 (en) * 2019-03-25 2024-09-03 President And Fellows Of Harvard College Compositions and methods for reducing tactile dysfunction, anxiety, and social impairment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL48441A (en) * 1974-11-28 1978-09-29 Sparamedica Ag Isoindole derivatives their manufacture and pharmaceutical compositions containing them
US4077978A (en) * 1974-11-28 1978-03-07 Hoffmann-La Roche Inc. Isoindole derivatives

Also Published As

Publication number Publication date
FR2355823A1 (fr) 1978-01-20
DE2723186A1 (de) 1977-12-08
US4167632A (en) 1979-09-11
AU2516177A (en) 1978-11-23
GB1568259A (en) 1980-05-29
NL7705590A (nl) 1977-11-23
CA1079288A (en) 1980-06-10
JPS52142059A (en) 1977-11-26
US4122265A (en) 1978-10-24
AU510035B2 (en) 1980-06-05
BE854780A (fr) 1977-11-18

Similar Documents

Publication Publication Date Title
FR2355823B1 (Direct)
DE2612889C2 (Direct)
DE2654225C3 (Direct)
CS177444B1 (Direct)
CS177749B1 (Direct)
CS177800B1 (Direct)
CH611751A5 (Direct)
CH613285A5 (Direct)
BG23356A1 (Direct)
BG25970A1 (Direct)
CH595073A5 (Direct)
CH599834A5 (Direct)
CH601629A5 (Direct)
CH601810A5 (Direct)
CH601846A5 (Direct)
CH601903A5 (Direct)
CH602230A5 (Direct)
CH602406A5 (Direct)
CH603972A5 (Direct)
CH604276A5 (Direct)
CH606475A5 (Direct)
CH606618A5 (Direct)
CH607740GA3 (Direct)
CH610840A5 (Direct)
DD126205A1 (Direct)

Legal Events

Date Code Title Description
ST Notification of lapse